Cardiac Guidance vs SENSICARDIAC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardiac Guidance

by Caption Health

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

AI Verdict

Tool A (Cardiac Guidance) focuses on empowering healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images for structural and functional assessment. In contrast, Tool B (SENSICARDIAC) is an AI-powered service that integrates with electronic stethoscopes to detect and classify heart murmurs. While both leverage AI for cardiac diagnosis, they utilize different modalities—ultrasound imaging versus auscultation—to address distinct aspects of cardiac health.

Choose Cardiac Guidance if…

Choose Cardiac Guidance if your primary need is to empower healthcare professionals, including those without extensive sonography experience, to acquire diagnostic-quality cardiac ultrasound images directly at the point of care. This tool is ideal for settings like emergency departments or critical care where immediate visual assessment of cardiac structure and function is crucial for rapid clinical decision-making.

View Cardiac Guidance →

Choose SENSICARDIAC if…

Choose SENSICARDIAC if you require an AI-powered, cloud-based solution for efficient heart murmur detection and classification, particularly in primary care, pediatrics, or telehealth environments. This tool is best suited for leveraging electronic stethoscopes to provide real-time analysis, helping to differentiate between pathological and physiological murmurs and optimize referral pathways.

View SENSICARDIAC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardiac Guidance	SENSICARDIAC
Deployment	Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care.	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Cardiac Guidance (Tool A) offers real-time, turn-by-turn on-screen probe movement instructions and automated quality assessment, specifically designed to enable non-expert ultrasound users to acquire diagnostic-quality images. This level of guided assistance for a complex imaging modality provides a significant usability advantage over SENSICARDIAC (Tool B), which offers a guided auscultation process for a comparatively less complex task.

Clinical Value

Cardiac Guidance

Cardiac Guidance (Tool A) is an FDA-cleared tool that enables the acquisition and interpretation of diagnostic-quality cardiac ultrasound images, including automated left ventricular ejection fraction (EF) calculation and support for 10 standard echocardiographic views. This provides comprehensive quantitative and qualitative diagnostic information for a wide range of cardiac conditions. SENSICARDIAC (Tool B), while also FDA-cleared, focuses on classifying heart murmurs as pathological or physiological, which is a valuable screening and diagnostic aid but offers a more focused clinical scope compared to a full cardiac ultrasound.

Pricing & Value

Tie

Both Cardiac Guidance (Tool A) and SENSICARDIAC (Tool B) state that pricing is available upon contacting the vendor, with no public details provided. Without transparent pricing or detailed information on their respective value propositions beyond their core functionalities, it is not possible to determine a winner in this dimension.

Enterprise Readiness

SENSICARDIAC

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong enterprise readiness. However, SENSICARDIAC (Tool B) offers cloud and desktop deployment and integrates with electronic stethoscopes, which are more ubiquitous and less capital-intensive than specialized ultrasound systems. This cloud-based approach and integration with common devices may offer greater flexibility, scalability, and potentially easier enterprise-wide rollout and maintenance compared to Cardiac Guidance (Tool A)'s deployment as a software accessory integrated with specific diagnostic ultrasound systems.

Innovation

Cardiac Guidance

Cardiac Guidance (Tool A) demonstrates higher innovation by democratizing a highly skilled and complex diagnostic procedure (cardiac ultrasound acquisition and interpretation) through real-time, turn-by-turn AI guidance for probe movement. This enables non-expert users to acquire diagnostic-quality images, significantly expanding access to critical cardiac assessments. SENSICARDIAC (Tool B)'s AI-powered murmur detection, while valuable, refines an existing diagnostic approach rather than fundamentally transforming the skill requirements for data acquisition to the same extent.

Support & Docs

Cardiac Guidance

While both tools lack explicit details on support and documentation in their structured facts, web searches indicate that Caption Health (Tool A) provides a dedicated 'Support' section on its website, including user manuals and contact information for customer support. DIACOUSTIC MEDICAL (Tool B) has a 'Contact Us' page, but a similarly structured or publicly visible support portal with detailed documentation is not as readily apparent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardiac Guidance	SENSICARDIAC
Primary Function	FDA-cleared AI tool for acquiring and interpreting diagnostic-quality cardiac ultrasound images at the point of care.	AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological.
Company	Caption Health	DIACOUSTIC MEDICAL (PTY)
Core Modality/Input	AI guidance for cardiac ultrasound image acquisition.	AI-powered heart murmur detection, integrates with electronic stethoscopes (e.g., 3M Littmannu00ae 3200).
Key Analysis/Output	Real-time AI guidance, automated quality assessment, auto-capture of diagnostic-quality images/video, automated left ventricular ejection fraction (EF) calculation, support for 10 standard echocardiographic views.	Classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological), detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators), real-time analysis.
Target User/Design Focus	Designed for use by non-expert ultrasound users.	Aids physicians in diagnosis and reduces unnecessary referrals; advanced remote cardiac care solution.

Videos

Demos, reviews, and walkthroughs featuring Cardiac Guidance and SENSICARDIAC.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for initial cardiac assessment, and what specific clinical scenarios are they best suited for?

Cardiac Guidance (Tool A) is designed for point-of-care ultrasound (POCUS) in acute settings like emergency departments and critical care, enabling non-expert users to acquire diagnostic-quality cardiac images for rapid assessment. SENSICARDIAC (Tool B) integrates with electronic stethoscopes to aid in heart murmur detection during routine physical exams or telehealth, helping physicians classify murmurs and reduce unnecessary referrals in primary care, internal medicine, and pediatrics.

What is the typical depth of EHR integration for each tool, specifically regarding the transfer of generated images, reports, and quantitative data?

Cardiac Guidance (Tool A), as part of the Caption AI platform, generates diagnostic-quality images, video clips, and automated LVEF calculations, aiming to improve clinical workflow and resource utilization. SENSICARDIAC (Tool B) provides detailed cardiac reports as downloadable PDFs and offers integrated stethoscope streaming, indicating a capability to transfer these reports and potentially other analysis data into EHR systems.

What are the reported accuracy and sensitivity metrics for each tool's primary function?

For Cardiac Guidance (Tool A), studies show 92.5% to 98.8% of AI-guided scans by non-expert users were of diagnostic quality for visual cardiac assessment, and its LVEF calculation is clinically validated with high accuracy comparable to conventional methods. SENSICARDIAC (Tool B)'s underlying technology for murmur detection has reported sensitivities ranging from 76.3% to 97.9% and specificities from 84.4% to 91.4% for detecting murmurs, with higher accuracy for clearly audible or moderate-to-severe valvular conditions.

What is the expected learning curve for a physician to become proficient with each system, and how does this impact their respective specialty fits?

Cardiac Guidance (Tool A) is specifically designed for healthcare providers without prior ultrasound experience, offering real-time, turn-by-turn instructions to significantly lower the learning curve for POCUS acquisition, making it suitable for emergency medicine and primary care. SENSICARDIAC (Tool B) features a guided auscultation process and real-time analysis, augmenting existing auscultation skills for a quick adoption by cardiologists, internal medicine, and pediatricians.

What kind of ongoing support and training are provided for each tool, and what is the typical time-to-value for a clinic or hospital implementing these solutions?

Caption Health (Tool A) offers customer support via email and provides Instructions for Use, with its acquisition by GE HealthCare expected to enhance resources for support and broader adoption. SENSICARDIAC (Tool B) is a cloud-based service with integrated stethoscope streaming, implying a potentially straightforward setup for immediate use, though specific details on support and time-to-value are not explicitly detailed.

What are the key considerations for a multi-site rollout of each tool, and are customer references available to demonstrate successful implementations in similar settings?

For Cardiac Guidance (Tool A), multi-site rollout considerations include compatibility with existing POCUS systems and training across various departments or facilities, with GE HealthCare's backing expected to facilitate broader market reach. SENSICARDIAC (Tool B)'s cloud-based nature and white-labeling option suggest scalability for multi-site deployments and integration with telehealth platforms, though specific customer references are not detailed in the provided information.